Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics

modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic

Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics

Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics

GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.

Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics

Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic

MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic

GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic

Industry News Monash University retains its N° 2 global ranking for Pharmacy and Pharmacology Addex Therapeutics

GPCR Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics

Frizzleds and Lgrs are dominant GPCRs that regulate stem cell self-renew abilities.

This scavenging function should be considered when evaluating the safety and therapeutic efficacy of